The article discusses the annual CPhI trade fair for the pharmaceutical ingredients industry that was held in Madrid, Spain. Topics discussed include the outsourcing of the industry through contract manufacturing organizations (CMOs), the focus of pharmaceutical companies in research and development (R&D...
The pace, scope, and variety of challenges we face as executives in Pharma are both invigorating and overwhelming. They span macro trends such as personalized medicine, real-world-evidence (RWE), onerous regulatory pressures, collaborative R&D and Digital health, as well as those specific to our...
Pharma manufacturing is complex and sometimes hazardous industry. The manufacturing process demands precise, safe and hygienic lifting at the weighing, processing and packaging stages. Our customized lifting solutions can address the main challenges in the industry like improving productivity plus large heal...
Then, Chi Cheng, President of Tianfu Group, stated in the speech that in the current business environment, from angles of policy support or the growth in demand for residents’ health consumption, the greater health industry has broad market prospects, but there are stillproblems for SMEs to im...
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Alex Guillen, global pharma and life sciences director at Tive, outlines the technological obstacles that lie ahead for the industry this year.
Key challenges in implementing MMM in pharma Challenge 1: Limited data availability and insight granularity Data availability is critical for any modelling effort, especially regarding sales data. The pharma industry’s regulatory requirements ensure the safe and effective provision of medicinal products to...
To successfully defeat attacks aimed at the pharma industry, it’s important to understand some of the top threats they are facing.
in 2019, the American pharmaceutical giant Pfizer sued the Indian generic drug company Sun Pharma, alleging that it had infringed on one of Pfizer's patents. Eventually, Sun Pharma was ordered to compensate Pfizer with 150 million US dollars. At the same time, if the core technologies and pat...
In another setback for the pharma industry, a US judge has rejected a bid to overturn the Medicare drug pricing negotiation brought by Bristol-Myers Squibb and Johnson & Johnson.
The big picture of talent scarcity in the pharma industry Scarce talent can be attributed to several different factors. It can be due to a limited number of people with a specific niche skill set or certification, or it can be the result of when market demand exceeds supply in a particular...